Patents by Inventor Patrick Elias

Patrick Elias has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • C-MET RECEPTOR REGULATION BY ANGIOTENSIN IV (AT4) RECEPTOR LIGANDS
    Publication number: 20080008701
    Abstract: The cell surface c-Met receptor, through which hepatocyte growth factor (HGF) signals are mediated, has now been identified as the Angiotensin-IV receptor (AT(4)R) in processes that include HGF-regulated cell motility, angiogenesis cancer metastasis and others. Disclosed are angiotensin-like factor compositions and methods for using them to diagnose, prevent and/or treat conditions associated with c-Met dysregulation, including altering hepatocyte growth factor activity or c-Met receptor activity by administering an angiotensin-like factor that specifically binds to a cell surface c-Met receptor.
    Type: Application
    Filed: July 6, 2007
    Publication date: January 10, 2008
    Applicant: WASHINGTON STATE UNIVERSITY RESEARCH FOUNDATION
    Inventors: Joseph Harding, John Wright, Patrick Elias, Brent Yamamoto